0 Комментарии
0 Поделились
421 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Antisense Oligonucleotide for Cardiometabolic Disorders Market Advances with Precision Therapeutics and RNA-Based Drug DevelopmentAccording to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Cardiometabolic Disorders Market The global antisense oligonucleotide for cardiometabolic disorders market size was valued at USD 310.32 million in 2024 and is expected to reach USD 1,135.19 million by 2032, at a CAGR of 17.60% during the forecast...0 Комментарии 0 Поделились 635 Просмотры 0 предпросмотр
-
Antisense Oligonucleotide Market for Neuromuscular Disorders to Expand with Advances in RNA-Targeted Therapies" According to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Neuromuscular Disorders Market CAGR Value The global antisense oligonucleotide for neuromuscular disorders market size was valued at USD 2.03 billion in 2024 and is expected to reach USD 4.87 billion by 2032, at a CAGR of 11.50% during the...0 Комментарии 0 Поделились 137 Просмотры 0 предпросмотр